Home Art Fresh from the biotech pipeline: FDA approvals settle in 2024, but what next?

Fresh from the biotech pipeline: FDA approvals settle in 2024, but what next?

Fresh from the biotech pipeline: FDA approvals settle in 2024, but what next?

After two volatile years, FDA approvals in 2024 settled closer to their 10-year average. Will nominated commissioner Marty Makary shake things up, or maintain a steady ship?

Access options

Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription

24,99 € / 30 days

cancel any time

Subscribe to this journal

Receive 12 print issues and online access

209,00 € per year

only 17,42 € per issue

Buy this article

Purchase on SpringerLink

Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Log in

Learn about institutional subscriptions

Read our FAQs

Contact customer support

References Senior, M. Nat. Biotechnol. 42, 355–361 (2024).

Article 
CAS 
PubMed 

Google Scholar 

Senior, M. Nat. Biotechnol. 41, 174–182 (2023).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Yiannopoulou, K. G., Anastasiou, A. I., Zachariou, V. & Pelidou, S. H. Biomedicines 7, 97 (2019).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Schmidt, M. E. et al. Neuropsychopharmacology 49, 1437–1447 (2024).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Shiga, T. Eur. Heart J. Suppl. 24, D11–D21 (2022). (Suppl. D).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Senior, M. Nat. Biotechnol. 42, 362–366 (2024).

Article 
CAS 
PubMed 

Google Scholar 

Senior, M. Nat. Biotechnol. 42, 1331–1338 (2024).

Article 
CAS 
PubMed 

Google Scholar 

Senior, M. Nat. Biotechnol. https://doi.org/10.1038/s41587-024-02506-7 (2024).

Article 
PubMed 

Google Scholar 

Download references

Author information Authors and Affiliations London, UK

Melanie Senior

Rights and permissions About this article

Cite this article Senior, M. Fresh from the biotech pipeline: FDA approvals settle in 2024, but what next?.
Nat Biotechnol (2025). https://doi.org/10.1038/s41587-025-02555-6

Download citation

Published: 20 January 2025

DOI : https://doi.org/10.1038/s41587-025-02555-6

Read whole article here

Leave a Reply

Your email address will not be published.